Green Fresh Biotechnology Company Limited (HKG:1084)
Hong Kong · Delayed Price · Currency is HKD 0.6300
-0.0200 (-3.08%)
Feb 13, 2026, 4:08 PM HKT
HKG:1084 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 940.22 | 989.26 | 1,174 | 1,411 | 947.58 | 738.61 | |
Revenue Growth (YoY) | -10.47% | -15.74% | -16.79% | 48.89% | 28.29% | -16.79% |
Cost of Revenue | 756.56 | 766.8 | 1,136 | 1,027 | 727.27 | 577.88 |
Gross Profit | 183.66 | 222.46 | 37.64 | 384.12 | 220.31 | 160.73 |
Selling, General & Admin | 131.78 | 125.21 | 115.12 | 104.91 | 89.15 | 75.73 |
Other Operating Expenses | -6.73 | -11.37 | -4.43 | -9.62 | -6.68 | -7.92 |
Operating Expenses | 126.04 | 114.82 | 107.52 | 95.66 | 82.47 | 67.81 |
Operating Income | 57.63 | 107.64 | -69.88 | 288.46 | 137.85 | 92.91 |
Interest Expense | -26.96 | -29.88 | -37.38 | -25.64 | -17.08 | -19.52 |
Interest & Investment Income | 0.53 | 0.69 | 0.4 | 0.13 | 0.16 | 1.82 |
Currency Exchange Gain (Loss) | 2.53 | 2.53 | -5.85 | -1.3 | -2.19 | -1.3 |
EBT Excluding Unusual Items | 34.62 | 80.97 | -112.71 | 261.65 | 118.74 | 73.91 |
Gain (Loss) on Sale of Investments | - | - | - | 0.11 | -2.77 | -0.04 |
Gain (Loss) on Sale of Assets | -0.1 | -0.1 | -0.18 | -0.17 | -0.92 | -0.12 |
Asset Writedown | - | - | - | - | -2.93 | - |
Pretax Income | 34.52 | 80.87 | -112.89 | 261.59 | 112.12 | 73.75 |
Income Tax Expense | 8.57 | 20 | -27.45 | 61.67 | 27.45 | 17.37 |
Earnings From Continuing Operations | 25.95 | 60.88 | -85.44 | 199.92 | 84.67 | 56.38 |
Minority Interest in Earnings | 1.07 | 1.29 | 0.12 | -0.69 | -0.25 | 1.64 |
Net Income | 27.02 | 62.17 | -85.33 | 199.23 | 84.42 | 58.02 |
Net Income to Common | 27.02 | 62.17 | -85.33 | 199.23 | 84.42 | 58.02 |
Net Income Growth | - | - | - | 136.00% | 45.50% | -30.44% |
Shares Outstanding (Basic) | 858 | 836 | 828 | 823 | 819 | 806 |
Shares Outstanding (Diluted) | 858 | 838 | 828 | 831 | 841 | 822 |
Shares Change (YoY) | 4.08% | 1.19% | -0.43% | -1.14% | 2.34% | 23.32% |
EPS (Basic) | 0.03 | 0.07 | -0.10 | 0.24 | 0.10 | 0.07 |
EPS (Diluted) | 0.03 | 0.07 | -0.10 | 0.24 | 0.10 | 0.07 |
EPS Growth | - | - | - | 139.51% | 41.67% | -43.48% |
Free Cash Flow | 57.37 | 82.49 | 84.75 | -69.39 | 7.16 | -16.05 |
Free Cash Flow Per Share | 0.07 | 0.10 | 0.10 | -0.08 | 0.01 | -0.02 |
Dividend Per Share | 0.011 | 0.011 | - | 0.044 | 0.033 | 0.042 |
Dividend Growth | - | - | - | 35.72% | -22.60% | -5.80% |
Gross Margin | 19.53% | 22.49% | 3.21% | 27.23% | 23.25% | 21.76% |
Operating Margin | 6.13% | 10.88% | -5.95% | 20.45% | 14.55% | 12.58% |
Profit Margin | 2.87% | 6.29% | -7.27% | 14.12% | 8.91% | 7.85% |
Free Cash Flow Margin | 6.10% | 8.34% | 7.22% | -4.92% | 0.76% | -2.17% |
EBITDA | 100.65 | 152.67 | -26.06 | 335.06 | 177.72 | 126.99 |
EBITDA Margin | 10.71% | 15.43% | -2.22% | 23.75% | 18.75% | 17.19% |
D&A For EBITDA | 43.02 | 45.03 | 43.82 | 46.6 | 39.88 | 34.08 |
EBIT | 57.63 | 107.64 | -69.88 | 288.46 | 137.85 | 92.91 |
EBIT Margin | 6.13% | 10.88% | -5.95% | 20.45% | 14.55% | 12.58% |
Effective Tax Rate | 24.83% | 24.73% | - | 23.57% | 24.49% | 23.56% |
Advertising Expenses | - | 3.09 | 2.6 | 2.19 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.